Yahoo India Web Search

Search results

  1. www.emcure.com › leadership › namita-vikas-thaparNamita Vikas Thapar

    Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business. Namita Thapar is passionate about improving women’s health in India and promoting youth entrepreneurship.

  2. Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies. She is also the founder of Thapar Entrepreneur Academy.

  3. 6 days ago · Namita Thapar, Executive Director of Emcure Pharmaceuticals, is a well-known figure in the pharmaceutical industry and one of the wealthiest Shark Tank India judges. She has appeared on the business reality show for three seasons.

  4. Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals . She has also been a prominent investor in Shark Tank India investing in over 100 companies.

  5. Namita Thapar is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies.

  6. Jul 1, 2024 · Namita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on Shark Tank, is set to earn approximately Rs 127 crore through the company's upcoming IPO. The issue ...

  7. 6 days ago · Namita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs 127.87 crore from the company's upcoming Initial Public Offering (IPO).

  8. Executive Director, India Business. Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, . Subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business.

  9. Jul 2, 2024 · Emcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita Thapar, a Shark Tank India investor. Thapar to sell around 12.68 lakh shares through the offer for ...

  10. Namita Thapar will offload a partial stake of about 12.68 lakh shares under the OFS component. Net proceeds from the IPO will be utilised by the company for debt repayment and general corporate ...

  1. Searches related to namita thapar company

    emcure